Newsletter
| Promoter: | OTCReporter.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| AXXE | $40000 | UNKNOWN |
| Max Profit: Pending | Gain at close: Pending | |
| *We think that this promoter is a part of a group of promoters. | ||
Our New Spotlight Stock is ...AXXE
AXXE: An International Pharmaceutical Company with BIG NEWS- could be very undervalued at its current level...
Here's Why:
Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products.
We've seen similar companies in this sector make huge moves.
AXXE acquired and owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally.
Start your research right away: http://www.axxesspharma.com/
Axxess has licensed Monurol a single dose antibiotic, specific treatment for Urinary track infections with Zambon SPA Switzerland. And exclusive license for marketing, and distribution of Trans dermal patches, and cosmetic masks and patches with Caleb Pharma.
AXXE distributes to several networks including: Physicians, Hospitals, Government Institutions, Defense Institutions and Pharmacies.
The company has just announced strategies to expand it marketing territory: http://finance.yahoo.com/news/Axxess-Pharma-Inc-Retains-AZ-iw-2650787197.html?x=0&.v=1
AXXE has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies.
They have specialized practice areas including Dermatology and Nephrology,Neurology and Urology!
Make sure to read the full marketing report: http://www.otcreporter.com/alerts.asp
Make sure to read the full marketing report: http://www.otcreporter.com/alerts.asp
OTCReporter.com, HotOTCChina.com, OTCPennystockreporter.com, OTCPennypicks.com, and Chartpenny.com (the “Websites”) are owned by Oceanic Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State") (Oceanic and Garden State are collectively referred to herein as the "LLC Companies) , both of which are New Jersey limited liability corporations (the Websites and its owners, the LLC Companies, and their affiliates, directors and officers and its immediate family members are referred to in our Disclaimer as "OTCR" or "we" or "us" or "our"). Because we receive monetary or securities compensation, most often in the form of common stock (hereafter referred to as the "Shares") for our dissemination of publicly disseminated information (the “Information”) regarding various issuers of securities, we disclose our specific compensation herein and in our individual reports of profiled issuers. The LLC Companies received forty thousand dollars from a non-affiliate third party shareholder of Axxess Pharma Inc. in return for OTCR’s services to publicly and electronically disseminate information pertaining to Axxess Pharma Inc. It is imperative that all readers of the above compensations disclosure carefully review our Disclaimer in its entirety, which contains important information about penny stocks, our operations, the limited nature of the Information and various risks attendant to the companies that we profile, including that: (a) we receive our compensation in free trading shares, which we will sell immediately upon their receipt as well as during the dissemination of such Information or within hours, days, weeks or months thereafter, or at any time; as a result, our selling activities will cause significant volatility in the Issuer’s stock price and/or significantly depress the Issuer’s stock price; (b) we will buy and sell the Shares in the open market before, during or after the dissemination of the Information or at any time, which will cause significant volatility in the Issuer’s stock price and/or significantly depress or increase the Issuer’s stock price; (c) there is an inherent and actual conflict of interest that exists between our Readers’ interests and our interests because we: (i) receive the Shares as compensation for disseminating the Information and thereafter sell those Shares at any time for monetary gain, including at the same time the Information is being disseminated or shortly thereafter or at any time; and (ii) buy and sells the Profiled Company’s shares in the open market at the same time or before the Information is being disseminated or shortly after the dissemination of the Information or at any time. Our gains from sale of the Shares may be substantial.